Peptidus Biotech
PrivateLast Round
Pre Seed
Dec 1, 2024
Company Overview
Peptidus Biotech operates in Healthcare & Life Sciences and is based in Brasília. Its latest recorded funding round was a Pre Seed round in December 2024.
Peptidus Biotech is a biotechnology company that develops novel bioactive peptides for animal health therapies using a proprietary AI-powered platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptidus Biotech Comparables
Compare Peptidus Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Animol Discovery | 77% | |
| Vetigenics Inc. | 73% | |
| Dechra Pharmaceuticals Limited | 66% |
For institutional investors. Book with your work email.
Peptidus Biotech Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Peptidus Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 87% MoM.
- Dec 1, 2024
Raised Pre Seed round with investors including Emerge Brasil.
For institutional investors. Book with your work email.
Peptidus Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Peptidus Biotech's valuation, stock price, and market status.
Is Peptidus Biotech a public or private company?
Peptidus Biotech is a private company.
What is the current stock price of Peptidus Biotech?
Peptidus Biotech is a private company, so its shares have no public market price. Caplight tracks Peptidus Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Peptidus Biotech worth (valuation)?
Valuation information for Peptidus Biotech is not publicly available.
Can I buy Peptidus Biotech stock?
Peptidus Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Peptidus Biotech's last funding round?
Peptidus Biotech's most recent funding round was Pre Seed on December 1, 2024.
Who are the main investors in Peptidus Biotech?
Key investors in Peptidus Biotech include Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Will Peptidus Biotech IPO soon?
No public IPO plans have been announced for Peptidus Biotech.
How can I track Peptidus Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Peptidus Biotech's shares on secondary markets.